Project Grant R21AG092994
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded $852,273 to The Trustees of Columbia University in the City of New York, Health Sciences Division, through the Aging Research program (CFDA 93.866) on September 1, 2025, for a project extending through May 31, 2030. This Project Grant funds a comprehensive genetic mapping study investigating the role of RNA modifications—specifically N6-methyladenosine (M6A) and pseudouridine (Ps)—in Alzheimer's disease (AD) pathogenesis...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded Columbia University's Health Sciences Division a $529,744 Project Grant effective February 15, 2026, through January 31, 2031, under the Aging Research program (CFDA 93.866). The award funds research investigating the mechanisms driving Alzheimer's disease progression through the entorhinal cortex-hippocampal circuit. The primary deliverables include longitudinal scientific investigations utilizing two-photon in...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded J. David Gladstone Institutes a $1,459,072 Project Grant on August 1, 2025, under the Aging Research program (CFDA 93.866) to investigate inhibitory neuron dysfunction in Alzheimer's disease (AD). The research will develop and implement innovative methodologies to monitor and manipulate two distinct inhibitory interneuron cell populations—parvalbumin (PVALB) and somatostatin (SST) cells—in both wildtype and AD-knock-in...
- Federal Project Grant Award Summary Duke University's Office of Research Administration was awarded $509,413 by the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) on September 15, 2025, for a project period extending through May 31, 2030. The award supports scientific research investigating epitranscriptomic regulation of microglia in Alzheimer's disease (AD), specifically examining how m6A (N6-methyladenosine) modifications of messenger RNA control microglial...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded a $134,325 Project Grant to Weill Medical College of Cornell University on August 15, 2025, under the Aging Research program (CFDA 93.866). The award supports biomedical research investigating the role of calvarial skeletal stem cells in modulating neuroinflammation and immune cell infiltration in Alzheimer's disease (AD). The project, with a completion date of May 31, 2027, will examine a novel bone-brain axis mechanism...
- Federal Grant Award Summary The National Institute on Aging awarded Icahn School of Medicine at Mount Sinai a $839,933 Project Grant under the Aging Research program (CFDA 93.866) to investigate the role of N6-methyladenosine (M6A) RNA modifications in microglial dysfunction and Alzheimer's disease pathogenesis. The five-year research project, which commenced September 1, 2025 and concludes May 31, 2030, will systematically map M6A RNA modification landscapes in microglia isolated from human...
- Federal Grant Award Summary New York University School of Medicine received a $3.104 million Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded September 15, 2025, with a completion date of May 31, 2030. The research initiative, titled "Peripheral Immunity and the Aging Brain: Studying the Relationship of Platelet and Neutrophil Activity with Markers of Vascular Contributions to Cognitive Decline and Dementia," delivers a...
- Federal Project Grant Award Summary The National Institute on Aging (NIA) awarded J. David Gladstone Institutes a Project Grant totaling $804,450 (awarded June 1, 2025, with completion targeted for March 31, 2030) under the Aging Research program (CFDA 93.866) to conduct biomedical research investigating the molecular mechanisms underlying Apolipoprotein E4 (APOE4)-driven pathogenesis in Alzheimer's disease (AD). The research will focus on targeting the growth factor protein NELL2 (Neural...
- Federal Project Grant Award Summary Yale University received a $461,146 Project Grant from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866), awarded on May 15, 2025, with completion targeted for April 30, 2027. The award funds research investigating the dysregulation of cortical astrocytes in Alzheimer's disease (AD) models. The primary deliverable is novel scientific research employing advanced mesoscopic imaging techniques to longitudinally measure...
- Federal Grant Award Summary The National Institute on Aging awarded a $610,836 Project Grant to the Broad Institute of MIT and Harvard (effective September 1, 2025, through May 31, 2030) under the Aging Research program (CFDA 93.866) to conduct systematic genetic research on mitonuclear interactions in aging and neurodegenerative diseases. The research will leverage two technological advances—mitochondrial DNA (mtDNA) editing using DDCBE base editors and biobank-scale analysis of mtDNA copy...
The National Institute on Aging (NIA) awarded Stony Brook University $454,937 under the Aging Research program (CFDA 93.866) on February 15, 2026, for a project period extending through January 31, 2028. This Project Grant supports research investigating the regulatory landscape of neurodegeneration through single-cell spatial multiomics analysis in Alzheimer's disease (AD). The research addresses critical knowledge gaps regarding how cells near AD pathological hallmarks—including amyloid-beta (Aβ) and tau—regulate themselves and respond to their microenvironment, with particular focus on understanding the complex interactions between neurodegeneration, glial cell-mediated inflammation, and chromatin accessibility as a dynamic regulator of transcription. The core deliverables involve integrating two previously unconnected layers of cellular regulatory machinery: epigenetic regulation (chromatin accessibility and transcription factor activity) and protein-level signaling transduction. By combining single-cell resolution with spatial proteomics capabilities, the research team will generate comprehensive multiomics datasets that characterize cell identity, signaling networks, transcriptional regulation, and functional cellular processes across heterogeneous brain tissue. This technological integration addresses a significant limitation in current omics tools, which typically lack either spatial information or adequate protein detection sensitivity, and will advance understanding of neurodegeneration mechanisms relevant to AD—the most common form of dementia in the United States.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $454.9k | 2/9/26 |